参考文献/References:
[1] 李晨阳.阿尔茨海默病的“中国处方”[J].科学新闻,2020,(05):60-61.
[2] Alzheimer's Association. 2008 Alzheimer's disease facts and figures[J]. Alzheimers Dement, 2008, 4(2): 110-133.
[3] Alzheimer A, Stelzmann RA, Schnitzlein HN, et al. An English translation of Alzheimer's 1907 paper, "Uber eine eigenartige Erkankung der Hirnrinde"[J]. Clin Anat, 1995, 8(6): 429-431.
[4] Hayashi T, Shimonaka S, Elahi M, et al. Learning deficits accompanied by microglial proliferation after the long-term post-injection of Alzheimer's disease[J]. Journal of Alzheimer's Disease, 2021, 79(4): 1701-1711
[5] Colonna M, Butovsky O. Microglia function in the central nervous system during health and neurodegeneration[J]. Annu Rev Immunol, 2017, 35(4): 441-468.
[6] Condello C, Yuan P, Schain A, et al. Microglia constitute a barrier that prevents neurotoxic protofibrillar Aβ42 hotspots around plaques[J]. Nat Commun, 2015, 6(1): 6176.
[7] Parkhurst CN, Yang G, Ninan I, et al. Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor[J]. Cell, 2013, 155(7): 1596-1609.
[8] Hristovska I, Pascual O. Deciphering resting microglial morphology and process motility from a synaptic prospect[J]. Front Integr Neurosci, 2015, 9(1): 73.
[9] Araki T, Ikegaya Y, Koyama R. The effects of microglia-and astrocyte-derived factors on neurogenesis in health and disease[J]. Eur J Neurosci, 2021, 54(5): 5880-5901.
[10] Shippy DC, Ulland TK. Microglial immunometabolism in alzheimer's disease[J]. Front Cell Neurosci, 2020, 14(9): 563446.
[11] Asai H, Ikezu S, Tsunoda S, et al. Depletion of microglia and inhibition of exosome synthesis halt tau propagation[J]. Nat Neurosci, 2015, 18(11): 1584-1593.
[12] Gratuze M, Chen Y, Parhizkar S, et al. Activated microglia mitigate Aβ-associated tau seeding and spreading[J]. J Exp Med, 2021, 218(8): e20210542.
[13] Sobue A, Komine O, Hara Y, et al. Microglial gene signature reveals loss of homeostatic microglia associated with neurodegeneration of Alzheimer's disease[J]. Acta Neuropathol Commun, 2021, 9(1): 1.
[14] Srinivasan K, Friedman BA, Etxeberria A, et al. Alzheimer's patient microglia exhibit enhanced aging and unique transcriptional activation[J]. Cell Rep, 2020, 31(13): 107843.
[15] Ndoja A, Reja R, Lee SH, et al. Ubiquitin ligase COP1 suppresses neuroinflammation by degrading c/EBPβ in microglia[J]. Cell, 2020, 182(5): 1156-1169.e12.
[16] Qasim A, Zahoor AS. Cofilin mediates LPS-Induced microglial cell activation and associated neurotoxicity through activation of NF-κB and JAK-STAT pathway[J]. Mol Neurobiol, 2018, 55(2): 1676-1691.
[17] Mazaheri F, Snaidero N, Kleinberger G, et al. TREM2 deficiency impairs chemotaxis and microglial responses to neuronal injury[J]. EMBO Rep, 2017, 18(7): 1186-1198.
[18] Hansen DV, Hanson JE, Sheng M. Microglia in alzheimer's disease[J]. J Cell Biol, 2018, 217(2): 459-472.
[19] Pekny M, Pekna M, Messing A, et al. Astrocytes: a central element in neurological diseases[J]. Acta Neuropathol, 2016, 131(3): 323-345.
[20] Wyss-Coray T, Rogers J. Inflammation in alzheimer disease-a brief review of the basic science and clinical literature[J]. Cold Spring Harb Perspect Med, 2012, 2(1): a006346.
[21] Colombo E, Farina C. Astrocytes: key regulators of neuroinflammation[J]. Trends Immunol, 2016, 37(9): 608-620.
[22] Choi SS, Lee HJ, Lim I, et al. Human astrocytes: secretome profiles of cytokines and chemokines[J]. PLoS One, 2014, 9(4): e92325.
[23] Kwon HS, Koh SH. Neuroinflammation in neurodegenerative disorders: the roles of microglia and astrocytes[J]. Transl Neurodegener, 2020, 9(1): 42.
[24] Sarkar S, Biswas SC. Astrocyte subtype-specific approach to Alzheimer's disease treatment[J]. Neurochem Int, 2021, 145(5): 104956.
[25] Bellaver B, Ferrari-Souza JP, Uglione DL, et al. Astrocyte biomarkers in alzheimer disease: a systematic review and meta-analysis[J]. Neurology, 2021(2021): 10.1212/WNL.0000000000012109.
[26] Fakhoury M. Microglia and astrocytes in alzheimer's disease: implications for therapy[J]. Curr Neuropharmacol, 2018, 16(5): 508-518.
[27] Matsuoka Y, Picciano M, Malester B, et al. Inflammatory responses to amyloidosis in a transgenic mouse model of Alzheimer's disease[J]. Am J Pathol, 2001, 158(4): 1345-1354.
[28] Nagele RG, D'andrea MR, Lee H, et al. Astrocytes accumulate A beta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains[J]. Brain Res, 2003, 971(2): 197-209.
[29] Sajja VS, Hlavac N, Vandevord PJ. Role of Glia in memory deficits following traumatic brain injury: biomarkers of Glia dysfunction[J]. Front Integr Neurosci, 2016, 10(2): 7.
[30] Staurenghi E, Cerrato V, Gamba P, et al, Oxysterols present in Alzheimer's disease brain induce synaptotoxicity by activating astrocytes: A major role for lipocalin-2[J]. Redox Biol, 2020, 39(2): 101837.
[31] Reid MJ, Beltran-Lobo P, Johnson L, et al. Astrocytes in tauopathies[J]. Front Neurol, 2020, 11(9): 572850.
[32] Kuhn S, Gritti L, Crooks D, et al. Oligodendrocytes in development, myelin Generation and beyond[J]. Cells, 2019, 8(11): 1424.
[33] Quintela-López T, Ortiz-Sanz C, Serrano-Regal MP, et al. Aβ oligomers promote oligodendrocyte differentiation and maturation via integrin β1 and Fyn kinase signaling[J]. Cell Death Dis, 2019, 10(6): 445.